Don Rule

Don Rule

Don founded Translational Software® to accelerate the use of molecular diagnostics. Prior to this he had a 14 year career at Microsoft, holding a variety of roles in providing Internet access to MSN, pioneering Virtual Private Networking products, and integrating Instant Messaging with Voice Over IP networks. Don founded the BioIT Alliance from within Microsoft to accelerate collaboration in translational research.

Read recent posts by this author below »

Government Health Initiatives Prioritize Pharmacogenetic Research

Pharmacogenomics promises to offer better treatment outcomes, fewer side effects, and a more personalized healthcare experience. To deliver on this promise, PGx must reach a wide audience, not just those with the

Implementing a Pharmacogenomics Program in a Large-Scale Rural Based Healthcare System

Most PGx programs operate in large academic medical centers within densely populated urban areas. These communities are often already rich in healthcare resources. But what about more rural populations?

PGx Testing Programs: A Win-Win for Both Employers and Employees

Today’s workforce wants more from its jobs and its employers. In a tight labor market with low unemployment, companies must find new ways to attract, engage and retain their best workers. Investing in employees

The Role of Clinical Pharmacogenomics in Managing Patient Expectations

By the end of 2018, more than 26 million consumers had undergone direct-to-consumer (DTC) genetic testing. These genetic tests promise to identify medically relevant genetic variants, identify a consumer’s genetic

3 Ways Pharmacogenomics is Securing its Place as a Standard of Care

A growing body of evidence has linked pharmacogenomic (PGx) testing to better patient outcomes, lower healthcare costs, reduced hospital readmission rates, and prevented adverse drug reactions. Change often comes to